Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,207,670
New position
Shares Held
3,335
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,569
of 3,139 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Financial Group, LLC/CA holds $7,135,398 across 7 Drug Manufacturers - General names. AMGN ranks #3 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 2 | ABBV |
AbbVie Inc.
|
4,956 | $1,247,127 | |
| 3 | AMGN |
Amgen Inc
This page
|
3,335 | $1,207,670 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,139 | $1,174,361 | |
| 5 | JNJ |
Johnson & Johnson
|
3,310 | $840,640 | |
| 6 | PFE |
Pfizer Inc
|
11,147 | $268,419 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,800 | $227,412 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,207,670 | 3,335 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||